<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02025686</url>
  </required_header>
  <id_info>
    <org_study_id>HBO12-04-2013</org_study_id>
    <secondary_id>2011-41-6327</secondary_id>
    <nct_id>NCT02025686</nct_id>
  </id_info>
  <brief_title>Hyperbaric Oxygen Therapy Attenuates Central Sensitization Induced by a Thermal Injury in Human Volunteers (HBO)</brief_title>
  <official_title>Hyperbaric Oxygen Therapy Attenuates Central Sensitization Induced by a Thermal Injury in Human Volunteers (HBO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Per Rotbøll Nielsen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this investigation is to observe if HBO have an anti-inflammatory effect in
      humans induced by tonic heat stimulation. It has been shown in animal studies with rats that
      HBO could reduce the paw edema induced by carrageenan as an inflammatory agent. The authors
      are not aware of similar studies in human subjects investigating this effect of HBO. Aim: To
      investigate the anti-inflammatory effect of HBO by reducing the hyperalgesia induced by heat
      stimulation in healthy subjects and promote future research and understanding of the
      anti-inflammatory processes in humans. The primary endpoint is a reduced area of secondary
      hyperalgesia after HBO.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of Hyperbaric Oxygen Therapy on Pain and Inflammation induced by Tonic Heat Stimulation in Human Volunteers</measure>
    <time_frame>8 weeks</time_frame>
    <description>Inflammation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain on Pain Scores on the Visual Analog Scale</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Pain</condition>
  <condition>Inflammation</condition>
  <condition>Hyperalgesia</condition>
  <arm_group>
    <arm_group_label>Hyperbaric Oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will breathe oxygen (FIO2 = 1.0) at 2.4 ATA in a hyperbaric chamber after the tonic heat stimulations. The duration of oxygen exposure is 90 min</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyperbaric Oxygen</intervention_name>
    <description>Subjects will breathe oxygen (FIO2 = 1.0) at 2.4 ATA in a hyperbaric chamber after the tonic heat stimulations. The duration of oxygen exposure is 90 min.</description>
    <arm_group_label>Hyperbaric Oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal ambient conditions</intervention_name>
    <description>Normal ambient conditions (1 ATA, FIO2 = 0.21)</description>
    <arm_group_label>Hyperbaric Oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 yr Approved physical health examination Healthy Male

        Exclusion Criteria:

          -  Arterial hypertension Chronic pain Claustrophobic tendency History of substance abuse
             Impaired cognitive abilities Inability to participate in quantitative sensory testing
             Incomplete understanding of Danish Neurological deficits Previous barotrauma or
             pneumothorax Previous head trauma Unable to equilibrate pressure in middle ear and/or
             sinuses
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2013</study_first_submitted>
  <study_first_submitted_qc>December 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2014</study_first_posted>
  <last_update_submitted>December 30, 2013</last_update_submitted>
  <last_update_submitted_qc>December 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 1, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Per Rotbøll Nielsen</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Hyperalgesia</keyword>
  <keyword>burn injury</keyword>
  <keyword>Hyperbaric Oxygen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

